Abbott has launched the professional version of its flash glucose monitoring system.
"Abbott has chosen India as the first country globally to launch this technology. The glucose assessment tool will cost Rs 1,999 for 14-days, will empower doctors to help their patients manage their diabetes effectively," said Mr Matthew Bates, R&D director, Abbott Diabetes Care, in a statement.
"The glucose monitoring system continuously measures glucose in interstitial fluid through a small filament that is inserted under the skin. It records glucose levels every 15 minutes, capturing up to 1,340 glucose readings over 14 days, thus giving the treating doctor comprehensive data for a complete glucose profile of their patient," explained Mr Bates.
After 14 days the doctor uses a flash glucose monitoring reader to scan the sensor and download the glucose results. This data can help doctors to make more informed treatment decisions.
